Streetbeat News

Price Targets

PNTG

Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on Pennant Group (NASDAQ:PNTG) and increased the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:15 pm

ENSG

Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on Ensign Group (NASDAQ:ENSG) and increased the price target from $115 to $127.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:14 pm

WNS

Citigroup analyst Ashwin Shirvaikar has reaffirmed a Buy rating on WNS (Hldgs) (NYSE:WNS) and increased the price target from $73 to $76.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:10 pm

TWKS

Citigroup analyst Ashwin Shirvaikar has maintained a Neutral rating on Thoughtworks Holding (NASDAQ:TWKS) and increased the price target from $4.5 to $5.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:07 pm

MS

Oppenheimer analyst Chris Kotowski has maintained an Outperform rating on Morgan Stanley (NYSE:MS) but has reduced the price target from $107 to $106.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:07 pm

TRV

Citigroup analyst Michael Ward has maintained a Neutral rating on Travelers Companies (NYSE:TRV) and increased the price target from $185 to $204.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:06 pm

HUM

Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on Humana (NYSE:HUM) and maintained a price target of $630.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:05 pm

TIXT

Citigroup analyst Ryan Potter has maintained a Neutral rating on TELUS International (NYSE:TIXT) and increased the price target from $7 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:04 pm

HCA

Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on HCA Healthcare (NYSE:HCA) and maintained a price target of $315.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 4:04 pm

FROG

In the past three months, 6 analysts have updated their ratings on JFrog (NASDAQ:FROG), with a positive shift in sentiment. The average 12-month price target is now $37.17, up 13.22% from the previous $32.83. Analysts from firms including Needham, Truist Securities, Oppenheimer, Morgan Stanley, and Piper Sandler have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. JFrog's financials show a solid revenue growth rate of 23.12% as of September 30, 2023, but it has a below-average net margin and ROE, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:01 pm